Nishida T - Search Results

1

Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial.

Komatsu Y, Doi T, Sawaki A, Kanda T, Yamada Y, Kuss I, Demetri GD, Nishida T. Komatsu Y, et al. Among authors: nishida t. Int J Clin Oncol. 2015 Oct;20(5):905-12. doi: 10.1007/s10147-015-0790-y. Epub 2015 Feb 6. Int J Clin Oncol. 2015. PMID: 25655899 Free PMC article. Clinical Trial.

2

Characterization of tyrosine kinase I domain c-kit gene mutation Asn655Lys newly found in primary jejunal gastrointestinal stromal tumor.

Kinoshita K, Hirota S, Isozaki K, Nishitani A, Tsutsui S, Watabe K, Tamura S, Ishikawa T, Kanda T, Nishida T, Hayashi N. Kinoshita K, et al. Among authors: nishida t. Am J Gastroenterol. 2007 May;102(5):1134-6. doi: 10.1111/j.1572-0241.2007.01180_11.x. Am J Gastroenterol. 2007. PMID: 17489795 No abstract available.

3

Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy.

Hasegawa J, Kanda T, Hirota S, Fukuda M, Nishitani A, Takahashi T, Kurosaki I, Tsutsui S, Hatakeyama K, Nishida T. Hasegawa J, et al. Among authors: nishida t. Int J Clin Oncol. 2007 Jun;12(3):212-7. doi: 10.1007/s10147-007-0657-y. Epub 2007 Jun 27. Int J Clin Oncol. 2007. PMID: 17566845

4

[Imatinib . Sunitinib].

Nishida T. Nishida T. Gan To Kagaku Ryoho. 2007 Aug;34(8):1196-200. Gan To Kagaku Ryoho. 2007. PMID: 17687201 Japanese.

5

An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors.

Takahashi T, Nakajima K, Nishitani A, Souma Y, Hirota S, Sawa Y, Nishida T. Takahashi T, et al. Among authors: nishida t. Int J Clin Oncol. 2007 Oct;12(5):369-74. doi: 10.1007/s10147-007-0705-7. Epub 2007 Oct 22. Int J Clin Oncol. 2007. PMID: 17929119

6

Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor.

Nishida T, Kanda T, Nishitani A, Takahashi T, Nakajima K, Ishikawa T, Hirota S. Nishida T, et al. Cancer Sci. 2008 Apr;99(4):799-804. doi: 10.1111/j.1349-7006.2008.00727.x. Epub 2008 Feb 21. Cancer Sci. 2008. PMID: 18294292 Free PMC article.

7

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202).

Nishida T, Shirao K, Sawaki A, Koseki M, Okamura T, Ohtsu A, Sugiyama T, Miyakawa K, Hirota S. Nishida T, et al. Int J Clin Oncol. 2008 Jun;13(3):244-51. doi: 10.1007/s10147-007-0746-y. Epub 2008 Jun 14. Int J Clin Oncol. 2008. PMID: 18553235 Clinical Trial.

8

[Contemporary treatment of gastrointestinal stromal tumors].

Nishida T. Nishida T. Gan To Kagaku Ryoho. 2008 Oct;35(10):1639-44. Gan To Kagaku Ryoho. 2008. PMID: 18931562 Review. Japanese.

9

Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version.

Nishida T, Hirota S, Yanagisawa A, Sugino Y, Minami M, Yamamura Y, Otani Y, Shimada Y, Takahashi F, Kubota T; GIST Guideline Subcommittee. Nishida T, et al. Int J Clin Oncol. 2008 Oct;13(5):416-30. doi: 10.1007/s10147-008-0798-7. Epub 2008 Oct 23. Int J Clin Oncol. 2008. PMID: 18946752

10

Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene.

Nishida T, Takahashi T, Nishitani A, Doi T, Shirao K, Komatsu Y, Nakajima K, Hirota S; Japanese Study Group on GIST. Nishida T, et al. Int J Clin Oncol. 2009 Apr;14(2):143-9. doi: 10.1007/s10147-008-0822-y. Epub 2009 Apr 24. Int J Clin Oncol. 2009. PMID: 19390946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,858 results

Search Page

Filters